human | Q5 |
P5552 | CNRS Talent page | jean-claude-do-rego |
P973 | described at URL | https://www.cnrs.fr/fr/personne/jean-claude-do-rego |
P166 | award received | CNRS Crystal medal | Q3002813 |
P106 | occupation | researcher | Q1650915 |
Q37364000 | A role for intestinal TLR4-driven inflammatory response during activity-based anorexia |
Q24599636 | Anti-ghrelin immunoglobulins modulate ghrelin stability and its orexigenic effect in obese mice and humans |
Q45197422 | Anti-neuropeptide Y plasma immunoglobulins in relation to mood and appetite in depressive disorder |
Q79845785 | Antidepressant-like effect of endomorphin-1 and endomorphin-2 in mice |
Q48249692 | Antinociceptive and antidepressant-like action of endomorphin-2 analogs with proline surrogates in position 2. |
Q28269772 | Behavioral actions of urotensin-II |
Q42667921 | Behavioral effects of urotensin-II centrally administered in mice |
Q42164059 | Biological activity of endomorphin and [Dmt1]endomorphin analogs with six-membered proline surrogates in position 2. |
Q45180464 | Characterization of antinociceptive activity of novel endomorphin-2 and morphiceptin analogs modified in the third position. |
Q46960010 | Comparisons between anxiety tests for selection of anxious and non anxious mice |
Q42732860 | Correction for "Synthesis of Mixed Opioid Affinity Cyclic Endomorphin-2 Analogues with Fluorinated Phenylalanines". |
Q39296580 | Design, synthesis and pharmacological characterization of endomorphin analogues with non-cyclic amino acid residues in position 2. |
Q63249355 | Effect of 2′,6′-dimethyl-l-tyrosine (Dmt) on pharmacological activity of cyclic endomorphin-2 and morphiceptin analogs |
Q48820591 | Effect of potent endomorphin degradation blockers on analgesic and antidepressant-like responses in mice |
Q37251392 | Emerging role of autoantibodies against appetite-regulating neuropeptides in eating disorders |
Q28550357 | French Intensive Care Society, International congress - Réanimation 2016 |
Q40259394 | Gut Commensal E. coli Proteins Activate Host Satiety Pathways following Nutrient-Induced Bacterial Growth |
Q36655222 | Hypericum caprifoliatum (Guttiferae) Cham. & Schltdl.: a species native to South Brazil with antidepressant-like activity |
Q37124526 | Increased Ghrelin but Low Ghrelin-Reactive Immunoglobulins in a Rat Model of Methotrexate Chemotherapy-Induced Anorexia |
Q35985375 | Kinetic studies of novel inhibitors of endomorphin degrading enzymes |
Q36610759 | Maintaining physical activity during refeeding improves body composition, intestinal hyperpermeability and behavior in anorectic mice |
Q46624328 | Modifications in avoidance reactions of mice, on a second exposure to the hot plate, resist to various amnesia-inducing treatments |
Q43921739 | Mouse lines differing in sensitivity to beta-CCM differ in tasks used for testing antidepressants |
Q39908953 | Novel endomorphin analogues with antagonist activity at the mu-opioid receptor in the gastrointestinal tract |
Q44337532 | Novel highly potent mu-opioid receptor antagonist based on endomorphin-2 structure |
Q38710203 | Opioid and Cannabinoid System in Food Intake |
Q44345880 | Opioid receptor binding and in vivo antinociceptive activity of position 3-substituted morphiceptin analogs |
Q50802363 | Pharmacological characterization of endomorphin-2-based cyclic pentapeptides with methylated phenylalanine residues. |
Q44339188 | Pharmacological properties of novel cyclic pentapeptides with µ-opioid receptor agonist activity |
Q46399968 | Pituitary adenylate cyclase-activating polypeptide inhibits food intake in mice through activation of the hypothalamic melanocortin system. |
Q34702087 | Potential of olfactory ensheathing cells from different sources for spinal cord repair |
Q34848266 | Regulation of feeding and anxiety by alpha-MSH reactive autoantibodies |
Q44803175 | Repeated administration of an aqueous spray-dried extract of the leaves of Passiflora alata Curtis (Passifloraceae) inhibits body weight gain without altering mice behavior |
Q40423267 | Sex differences in response to activity-based anorexia model in C57Bl/6 mice. |
Q35564817 | Sex-related effects of nutritional supplementation of Escherichia coli: relevance to eating disorders |
Q43170583 | Structural and pharmacological characteristics of chimeric peptides derived from peptide E and beta-endorphin reveal the crucial role of the C-terminal YGGFL and YKKGE motifs in their analgesic properties |
Q46708649 | Synthesis and antinociceptive activity of cyclic endomorphin-2 and morphiceptin analogs |
Q48384974 | Synthesis and biological evaluation of cyclic endomorphin-2 analogs |
Q48217158 | Synthesis and biological evaluation of novel peripherally active morphiceptin analogs |
Q44333625 | Synthesis and characterization of potent and selective mu-opioid receptor antagonists, [Dmt(1), D-2-Nal(4)]endomorphin-1 (Antanal-1) and [Dmt(1), D-2-Nal(4)]endomorphin-2 (Antanal-2). |
Q35615157 | Synthesis of mixed opioid affinity cyclic endomorphin-2 analogues with fluorinated phenylalanines |
Q37727696 | The Spontaneous Autoimmune Neuromyopathy in ICOSL-/- NOD Mice Is CD4+ T-Cell and Interferon-γ Dependent |
Q46615568 | The antidepressant-like effect of Hypericum caprifoliatum Cham & Schlecht (Guttiferae) on forced swimming test results from an inhibition of neuronal monoamine uptake |
Q36747911 | The endomorphin system and its evolving neurophysiological role |
Q43067753 | The novel endomorphin degradation blockers Tyr-Pro-DClPhe-Phe-NH (EMDB-1) and Tyr-Pro-Ala-NH (EMDB-2) prolong endomorphin-2 action in rat ileum in vitro |
Q44334395 | Uliginosin B presents antinociceptive effect mediated by dopaminergic and opioid systems in mice |
Q28254994 | Uliginosin B, a phloroglucinol derivative from Hypericum polyanthemum: a promising new molecular pattern for the development of antidepressant drugs |
Q28287953 | Urotensin II, from fish to human |
Q44337660 | [Dmt1, d-1-Nal3]morphiceptin, a novel opioid peptide analog with high analgesic activity |
Search more.